Methods | Single centre, randomised, controlled trial conducted in Milan, Italy. Study period: not stated | |
Participants | 16 infants receiving mechanical ventilation (< 31 weeks' GA) with ECHO evidence of PDA were randomised Ibuprofen: 8 neonates, median and range GA 29 (27 to 31) weeks, BW 855 (620 to 1620) grams , postnatal age 24 (10 to 53) hours, 4 boys, 4 girls Indomethacin: 8 neonates, median and range GA 28 (25 to 300) weeks, BW 820 (600 to 1390) grams, postnatal age 29 (5 to 120) hours, 5 boys, 3 girls |
|
Interventions | Ibuprofen: IV 10 mg/kg infused over 1 minute as a first dose and a second and third dose administered at 24‐hour intervals provided that no significant adverse effect was observed Indomethacin: IV 0.2 mg/kg infused over 1 minute and a second and third dose of 0.1 mg/kg were administered at 24‐hour intervals provided no significant adverse effects were observed |
|
Outcomes | PDA closure, cerebral blood flow velocity, near‐infrared spectroscopy was used to measure changes in cerebral blood volume and in oxidised cytochrome oxidase concentration | |
Notes | The results of this study were reported in abstract form with the same number of infants enrolled (Mosca 1996). Whether there was any overlap with an additional study was unclear (Mosca 1997a) No information on funding provided |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No information provided |
Allocation concealment (selection bias) | Unclear risk | The infants were randomised. No other information provided |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Clinicians were aware of group assignments |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | It was not stated whether the cardiologist performing the ECHOs was blinded to the treatments or not |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Outcomes reported on all randomised infants |
Selective reporting (reporting bias) | Unclear risk | Study protocol was not available to us so we could not ascertain if there were deviations from the protocol |
Other bias | Low risk | Appeared free of other bias |